Logo

ASTM E1052-11

Historical Revision

Standard Test Method for Efficacy of Antimicrobial Agents Against Viruses in Suspension (Withdrawn 2011)

$73.00

$73.00

$131.40


Sub Total (1 Item(s))

$ 0.00

Estimated Shipping

$ 0.00

Total (Pre-Tax)

$ 0.00


...

1.1 This test method is intended to demonstrate the virucidal activity of test substances with viruses in suspension.

1.2 It is the responsibility of the investigator to determine whether Good Laboratory Practice regulations (GLPs) are required and to follow them where appropriate (40 CFR, Part 160 for EPA submissions and 21 CFR, Part 58 for FDA submissions).

1.3 Refer to the appropriate regulatory agency for performance standards of virucidal efficacy.

1.4 The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard.

1.5 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use. The user should consult a reference for the laboratory safety recommendations.

This test method is to determine if a test substance can inactivate viruses in suspension.

Regulatory agencies may require additional testing using in vitro (Test Methods E1053, E2197) or in vivo (Test Method E1838) carrier tests for product registration purposes.

SDO ASTM: ASTM International
Document Number E1052
Publication Date Oct. 1, 2011
Language en - English
Page Count 3
Revision Level 11
Supercedes
Committee E35.15
Publish Date Document Id Type View
Jan. 1, 2020 E1052-20 Revision
Oct. 1, 2011 E1052-11 Revision
Oct. 10, 1996 E1052-96R02 Revision
Oct. 10, 1996 E1052-96 Revision